Jakafi 10 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DX25F6AHH
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $121,157
Award facts
- Contract value 100% obligated
- $121,156.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on September 25, 2025, for the supply of Jakafi 10 mg tablets (60-count units) under a firm fixed-price contract. The award, valued at $121,156.50, carries an ultimate completion date of September 26, 2025. This delivery order was issued without a set-aside designation and will be performed at the contractor's Park Ridge facility. The award is funded through the Medical Supply Chain, a defense agency, reflecting the Department of Defense's ongoing pharmaceutical supply requirements.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency (DLA) under the SPE2DB program, valued at $499,999,999 and valid through November 2026. This master contract enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities worldwide. The current award for Jakafi—a prescription medication used in the treatment of certain blood disorders—exemplifies the contractor's role as a critical supplier in the federal pharmaceutical supply chain, providing direct distribution of branded and generic prescription drugs to Department of Defense healthcare facilities across the nation.
Quick answers
Who was awarded contract SPE2DX25F6AHH?
SPE2DX25F6AHH was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on September 25, 2025.
How much is contract SPE2DX25F6AHH worth?
The government has obligated $121,157 on SPE2DX25F6AHH.
Is contract SPE2DX25F6AHH an order under another contract?
Yes. SPE2DX25F6AHH is a delivery order under SPE2DX15D9114, an indefinite delivery contract.
Was contract SPE2DX25F6AHH competed?
The extent of competition for SPE2DX25F6AHH was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award